Innovation Showcase

Innovation Showcase Thursday lunchtime

Innovation Showcase: BioLamina

6/21/2018
11:30 - 12:30

Presented by: BioLamina 

Presentations:

Send Email for Kristian Tryggvason

Malin Parmar

Lund University, Sweden

Malin Parmar is a professor in cellular neuroscience at Lund University. Together with her lab she has shown in a series of high profile publications how human fibroblasts can be converted into neurons, how glial cells can be reprogrammed into neurons in vivo, and how functional dopamine neurons can be generated from human embryonic stem cells. She is the recipient of an ERC starting grant and an ERC Consolidator grant as well as a VR Consolidator Grant. In 2016 she was awarded a New York Stem Cell Foundation – Robertson investigator award.
Her research has a strong translational focus and she collaborates with Industry partners to develop new, stem cell based therapies for Parkinson’s Disease.

Presentation(s):

Send Email for Malin Parmar

Fredrik Lanner

Karolinska Institute and Karolinska University Hospital, Sweden

Assistant Professor Fredrik Lanner
CLINTEC, Karolinska Institutet, Sweden

Fredrik Lanner undertook his PhD thesis at the Karolinska Institutet in 2008 followed by postdoctoral research in Janet Rossants laboratory at The Hospital for Sick Children, Toronto. In Toronto he studied the role of FGF signaling in the early mouse embryo (Yamanaka et. al., Development 2010). Having returned to Karolinska Institutet, he started his independent lab in 2013. The lab has established a transcriptional road map of lineage specification and identified a distinct X-chromosome dosage compensation process that operates in the human embryo (Petropoulos et. al., Cell 2016). Through a proteomic approach the lab has identified cell surface markers that distinguish naïve and primed pluripotent stem cells (Collier et. al., Cell Stem Cell 2017).

Presentation(s):

Send Email for Fredrik Lanner


Assets

Innovation Showcase: CTG BIOLAMININTM 521 – A BIOLOGICALLY RELEVANT CULTURE MATRIX, ENABLING PRE-CLINICAL RESEARCH PROTOCOLS TO BE TRANSLATED FOR CLINICAL TRIALS - BioLamina



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Innovation Showcase: CTG BIOLAMININTM 521 – A BIOLOGICALLY RELEVANT CULTURE MATRIX, ENABLING PRE-CLINICAL RESEARCH PROTOCOLS TO BE TRANSLATED FOR CLINICAL TRIALS - BioLamina